Advertisement

Topics

Celgene Spinout Celularity Raises $250 Million To Develop Placental Cells To Attack Cancer

04:00 EST 15 Feb 2018 | Forbes

Celularity, a company spun out of biotech giant Celgene, announced this morning it has raised $250 million with the aim of developing cells from placentas to attack tumors and to treat Crohn’s disease. In addition to being awash in cash, the company is flooded with big dreams.

Original Article: Celgene Spinout Celularity Raises $250 Million To Develop Placental Cells To Attack Cancer

NEXT ARTICLE

More From BioPortfolio on "Celgene Spinout Celularity Raises $250 Million To Develop Placental Cells To Attack Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Crohn's Disease (CD)
Crohn’s disease (CD) is a long-term condition that causes inflammation of the lining of the digestive system.  Inflammation can affect any part of the digestive system, from the mouth to the back passage, but most commonly occurs in the last s...